This study will assess the efficacy of a two week treatment with BGG492 in patients with chronic subjective Tinnitus.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
96
Novartis Investigative Site
Berlin, Germany
Novartis Investigative Site
Frankfurt, Germany
Novartis Investigative Site
Lepzig, Germany
Novartis Investigative Site
Groningen, Netherlands
Change in tinnitus loudness using a visual analogue scale (VAS)
Time frame: after 15 days of treatment
Change in Clinical status of tinnitus (patients' reaction to tinnitus) using the TBF-12 (Tinnitus Impairment Questionnaire)
Time frame: after 15 days of treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.